Elite in Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)

Bettina F. Winzeler

Basel, BS, CH 
Elite in Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
Basel, BS, CH 
OverviewLocationsClinical Research

Overview

Bettina Winzeler practices in Basel, Switzerland. Ms. Winzeler is rated as an Elite expert by MediFind in the treatment of Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH). Her top areas of expertise are Diabetes Insipidus (DI), Low Sodium Level, Neurohypophyseal Diabetes Insipidus, and Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH).

Her clinical research consists of co-authoring 71 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 9 articles in the study of Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH).

Gender
Female

Locations

Basel, BS, Switzerland
Other Locations
Zurich, ZH, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues - a Randomized, Double-blind, Placebo-controlled Trial
Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues - a Randomized, Double-blind, Placebo-controlled Trial
Enrollment Status: Completed
Publish Date: September 13, 2022
Intervention Type: Drug
Study Phase: Phase 2
Effects of Glucagon-Like Peptide-1 Analogs on Sexuality - a Randomized, Double-blind, Placebo-controlled Trial With Crossover Design
Effects of Glucagon-Like Peptide-1 Analogs on Sexuality - a Randomized, Double-blind, Placebo-controlled Trial With Crossover Design
Enrollment Status: Completed
Publish Date: September 07, 2022
Intervention Type: Drug
Study Phase: Phase 2
Circulating Oxytocin Changes in Response to the Oxytocin System Stimulator MDMA in Patients With Diabetes Insipidus and Healthy Controls
Circulating Oxytocin Changes in Response to the Oxytocin System Stimulator MDMA in Patients With Diabetes Insipidus and Healthy Controls
Enrollment Status: Completed
Publish Date: April 13, 2022
Intervention Type: Diagnostic test
Study Phase: Not Applicable
View 2 Less Clinical Trials

71 Total Publications

A post-hoc internal validation of arginine-stimulated copeptin cut-offs for diagnosing AVP deficiency (central diabetes insipidus).
A post-hoc internal validation of arginine-stimulated copeptin cut-offs for diagnosing AVP deficiency (central diabetes insipidus).
Journal: Pituitary
Published: April 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Winzeler's expertise for a condition
ConditionClose
View All 8 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile